Biotage®
(STO: BIOT), announces the launch of Biotage® ACT (Anti Cross Talk)
Plate Adapter, an innovative solution for prevention of well to well
cross contamination during extract evaporation.
Uppsala,
Sweden (July 24, 2015) -- Biotage®
(STO: BIOT), a leading global supplier of solutions and technology
for analytical and medicinal chemistry, announces the launch of
Biotage® ACT (Anti Cross Talk) Plate Adapter, an innovative solution
for prevention of well to well cross contamination during extract
evaporation.
Biotage®
ACT Plate Adapter is an essential accessory for evaporation devices.
Constructed from robust, high grade anodized aluminum, it fits on top
of the 96-well collection plate containing the sample during
evaporation. The plate adapter is compatible with straight needle
evaporation devices such as the Biotage® SPE Dry 96 and Biotage®
SPE Dry Dual systems, and does not require any changes to the
existing analytical method.
The
Biotage® ACT Plate Adapter is designed to fit on top of the 96-well
collection plate, is reusable and easy to use. Evaporated gases are
directed away from the sample wells, eddies are reduced, and the
plate adapter reduces the open surface area of the top of the wells,
lessening the likelihood that material can re-enter and contaminate
adjacent wells.
"During
evaporation a proportional amount of analytes present in an extracted
sample can contaminate surrounding wells by being carried with the
volatilized solvent. If the analyte concentration in one well is
considerably higher than the analyte concentration in the surrounding
wells it has the potential to cause a clinically significant and
erroneous change to the adjacent samples. Biotage® ACT Plate Adapter
is the first commercially available device to address the issue of
cross talk on evaporation" says Dr. Claire Desbrow, Product
Manager, Analytical Chemistry, Biotage.
The
plate adapter can be incorporated into existing assays without the
need for changing any other aspects of the method, and there is
minimal impact of solvent drying times.
For
further information, visit http://www.biotage.com or call:
In
Europe: +46 18 56 57 10
In
North America: (Toll Free) 1 800 446 4752
In
Japan: +81 422 28 1233
Other
areas, please call: +46 18 56 57 10
-Ends-
For
further press information at Biotage, please contact:
James
Churchill
Marketing
Communications
Biotage
GB Limited
Distribution
Way
Dyffryn
Business Park
Ystrad
Mynach
Hengoed,
Wales CF82 7TS
United
Kingdom
Tel:
+44 (0)1443 811 849
Mobile:
+44(0)7875484778
Email:
james.churchill@biotage.com
About
Biotage
Biotage
offers solutions, knowledge and experience in the areas of analytical
and medicinal chemistry. Customers include the world's top
pharmaceutical and biotechnology companies, as well as leading
academic institutes. The company is headquartered in Uppsala, Sweden,
with offices in China, Japan, the United Kingdom, the United States
and a worldwide network of distributors. Biotage has 293 employees
with sales of 490 MSEK in 2014. Biotage is listed on the NASDAQ OMX
Nordic Stock Exchange. Website: http://www.biotage.com.